These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 9237184

  • 21. [Detection of HER-2/neu in breast carcinoma].
    Skálová A, Vanĕcek T, Losan F, Papoutsidesová, Fínek J.
    Cas Lek Cesk; 2003 Feb; 142(2):93-8. PubMed ID: 12698536
    [Abstract] [Full Text] [Related]

  • 22. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
    Liu HL, Gandour-Edwards R, Lara PN, de Vere White R, LaSalle JM.
    Cancer J; 2001 Feb; 7(5):395-403. PubMed ID: 11693898
    [Abstract] [Full Text] [Related]

  • 23. Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
    Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
    Cancer Res; 1995 Dec 01; 55(23):5693-8. PubMed ID: 7585656
    [Abstract] [Full Text] [Related]

  • 24. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.
    Riben MW, Malfetano JH, Nazeer T, Muraca PJ, Ambros RA, Ross JS.
    Mod Pathol; 1997 Aug 01; 10(8):823-31. PubMed ID: 9267826
    [Abstract] [Full Text] [Related]

  • 25. Algorithm for the diagnosis of HER-2/neu status in breast-infiltrating carcinomas.
    Falo C, Moreno A, Lloveras B, Figueras A, Varela M, Escobedo A.
    Am J Clin Oncol; 2003 Oct 01; 26(5):465-70. PubMed ID: 14528071
    [Abstract] [Full Text] [Related]

  • 26. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec 01; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 27. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
    Afify AM, Werness BA, Mark HF.
    Exp Mol Pathol; 1999 Jun 01; 66(2):163-9. PubMed ID: 10409445
    [Abstract] [Full Text] [Related]

  • 28. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
    Lin F, Shen T, Prichard JW.
    Diagn Cytopathol; 2005 Dec 01; 33(6):376-80. PubMed ID: 16299744
    [Abstract] [Full Text] [Related]

  • 29. Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization.
    Isola J, Tanner M, Forsyth A, Cooke TG, Watters AD, Bartlett JM.
    Clin Cancer Res; 2004 Jul 15; 10(14):4793-8. PubMed ID: 15269154
    [Abstract] [Full Text] [Related]

  • 30. Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
    Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
    J Clin Oncol; 2004 Aug 01; 22(15):3126-32. PubMed ID: 15284264
    [Abstract] [Full Text] [Related]

  • 31. HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma.
    Bozzetti C, Personeni N, Nizzoli R, Guazzi A, Flora M, Bassano C, Negri F, Martella E, Naldi N, Franciosi V, Cascinu S.
    Cancer; 2003 Oct 25; 99(5):310-5. PubMed ID: 14579298
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.
    Mezzelani A, Alasio L, Bartoli C, Bonora MG, Pierotti MA, Rilke F, Pilotti S.
    Br J Cancer; 1999 May 25; 80(3-4):519-25. PubMed ID: 10408862
    [Abstract] [Full Text] [Related]

  • 34. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
    Wu Y, Soslow RA, Marshall DS, Leitao M, Chen B.
    Gynecol Oncol; 2004 Dec 25; 95(3):570-5. PubMed ID: 15581965
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.
    Tiwari RK, Borgen PI, Wong GY, Cordon-Cardo C, Osborne MP.
    Anticancer Res; 1992 Dec 25; 12(2):419-25. PubMed ID: 1349794
    [Abstract] [Full Text] [Related]

  • 37. [HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].
    Akhdar A, Bronsard M, Lemieux R, Geha S.
    Ann Pathol; 2011 Dec 25; 31(6):472-9. PubMed ID: 22172120
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis.
    Gjerdrum LM, Sorensen BS, Kjeldsen E, Sorensen FB, Nexo E, Hamilton-Dutoit S.
    J Mol Diagn; 2004 Feb 25; 6(1):42-51. PubMed ID: 14736826
    [Abstract] [Full Text] [Related]

  • 40. Assessing sequential oncogene amplification in human breast cancer.
    Janocko LE, Lucke JF, Groft DW, Brown KA, Smith CA, Pollice AA, Singh SG, Yakulis R, Hartsock RJ, Shackney SE.
    Cytometry; 1995 Sep 01; 21(1):18-22. PubMed ID: 8529465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.